Phio Pharmaceuticals Corp. — Director's Dealing 2024

Sep 13, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Phio Pharmaceuticals Corp. (PHIO)
CIK: 0001533040
Period of Report: 2024-09-11

Reporting Person: Bitterman Robert J (Director, Chairman, Pres & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-09-11	Common Stock, $0.0001 par value	A	15500	—	Acquired	17832	Direct

Footnotes

F1: Represents shares underlying a restricted stock unit, which shares will vest in one year on the first anniversary.

F2: Includes shares of common stock underlying unvested restricted stock units.